Skip to content

Neonatal Data and Biobank to Study Factors Influencing Development in Preterm Infants Born at <32 Weeks' Gestation and/or <1500 g Birth Weight

Establishing a Neonatal Data and Biobank to Study Factors Influencing Development in Preterm Infants Born at <32 Weeks' Gestation and/or <1500 g Birth Weight

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07490912
Acronym
Neo-Life
Enrollment
1300
Registered
2026-03-24
Start date
2026-03-13
Completion date
2056-03-13
Last updated
2026-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Birth, Prematurity Complications, Preterm Infant Development, Preterm Infant Health

Keywords

prematurity, preterm infants, very low birth weight infants, very preterm infants, gestational age <32 weeks, Premature birth, <32 weeks gestational age, very low birth weight, <1500 g birth weight, database, biobank, preterm infant development, preterm infant health, preterm infant long-term outcome, prematurity complications, risk and protective factors of preterm infant development

Brief summary

The Neo-Life project aims to establish a prospective neonatal data and biobank to investigate factors influencing the short- and long-term development of very preterm infants. Advances in neonatal care have significantly improved survival rates of infants born with a gestational age of less than 32 weeks and/or a birth weight below 1500 g. However, these infants remain at high risk for multiple complications affecting neurological, pulmonary, cardiovascular, renal, and other organ systems, which may lead to long-term morbidity and reduced quality of life. Identifying early risk and protective factors is therefore essential to improve outcomes and develop targeted interventions. The primary objective of the project is the prospective and structured collection of clinical data as well as biological samples within a standardized interdisciplinary follow-up program for preterm infants. The study aims to identify biological, clinical, and environmental factors associated with the development and long-term outcomes of different organ systems. The study population includes infants born with a gestational age of less than 32 weeks and/or a birth weight below 1500 g who receive care at the perinatal center of the University Hospital Cologne. Participation requires informed consent from the parents or legal guardians. There are no specific exclusion criteria. Participants will be followed within the established preterm follow-up program over several years, allowing longitudinal assessment of clinical outcomes and developmental trajectories. Primary outcome is survival without impairment (e.g. neurocognitive, pulmonal, cardiovascular, renal) at the age of 5 years. Secondary outcomes include duration of breastfeeding, nutritional status, body mass index, and parental stress and bonding. In addition, biological samples will be collected to enable the creation of epigenetic, gene expression, and cytokine profiles. These data will contribute to the identification of predictive biomarkers that may help stratify risk and guide individualized preventive or therapeutic strategies in preterm infants. By combining comprehensive clinical data with biological samples in a dedicated data and biobank, the Neo-Life project aims to generate a valuable resource for translational research. The findings are expected to improve understanding of the mechanisms underlying organ development and long-term health in preterm infants and to support the development of early interventions that may prevent or mitigate adverse outcomes.

Interventions

None listed

Sponsors

University Hospital of Cologne
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Preterm infants born \<32 weeks' gestational age and/or with a birth weight \< 1500 g * Informed consent of parents/ legal guardians

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Survival without cognitive impairmentat the age of 5 yearsNeurocognitive Impairment is defined as Bayley Scales of Infant Development III (Bayley - III) cognitive score less than 84.
Survival without impaired motor functionat the age of 5 yearsMotor function impairment is defined as Gross Motor Function Classification System (GMFCS) level of 2 or higher.
Survival without visual impairmentat the age of 5 yearsVisual impairment is defined as need of visual aid or blindness.
Survival without hearing impairmentat the age of 5 yearsHearing impairment is defined as hearing with amplification or hearing loss despite amplification.
Survival without seizuresat the age of 5 yearsThe occurrence of seizures is assessed during follow-up visits.

Secondary

MeasureTime frameDescription
Duration of breast feeding2 yearsDuration of breast feeding is assessed during follow-up visits.
Weight gainbirth to the age of 18 yearsWeight progression is assessed using percentile curves (Fenton, WHO). This includes assessing wether the weight trajectory lies within the normal range (10th - 90th percentile) and wether percentile shifts occur.
Growth in length/heightbirth to the age of 18 yearsGrowth in length/height is assessed using percentile curves (Fenton, WHO). This includes assessing wether the length/height trajectory lies within the normal range (10th - 90th percentile) and wether percentile shifts occur.
General Movementscorrected 3 months of ageEarly infant development will be assessed using General Movements Assessment by Prechtl. It is a validated diagnostic tool for the functional assessment of the young nervous system.
Maternal depressionat the corrected age of 35-40 weeks' gestational age, at the corrected age of 6 months and at the corrected age of 24 monthsThe German long form of the Center for Epidemiological Studies Depression Scale (CES-D) will be used to assess maternal depression. The self-report questionnaire consists of 20 questions and its score ranges from 0 to 60. A score of 15 or higher indicates a risk of depression.
Post-traumatic Stressat the corrected age of 6 monthsPost-traumatic stress is assessed with the impact of event scale - revised (IES-R). The self-report questionnaire consists of 22 questions and includes 3 sub-scales (intrusion, avoidance and hyperarousal). The overall score ranges from -4,36 to 2,99. A result above 0 is interpreted to indicate a risk of post-traumatic stress disorder.
Parental Bondingcorrected age of 6 and 24 monthsParental Bonding is assessed using the parental bonding questionnaire (PBQ), which consists of 25 items and includes 4 sub-scales (impaired bonding, rejection and anger, anxiety about care, risk of abuse). A higher the score indicates a higher risk of a disorder in each area of the sub-scale.
Social Supportat the corrected age of 35-40 weeks' gestational age and at the corrected age of 24 monthsSocial support is assessed using the short version of the German questionnaire for social support (Fragebogen zur sozialen Unterstützung, questionnaire on social support) scale (F-SozU K-22). The questionnaire includes 22 items and its scale ranges from a minimum of 22 points to a maximum of 110 points. The higher the score, the better the subjectively perceived or anticipated support.

Countries

Germany

Contacts

CONTACTCharlotte S Schömig, Dr. med.
charlotte.schoemig@uk-koeln.de+49 221 478 85663
CONTACTAngela Kribs, Apl. Prof. Dr.
angela.kribs@uk-koeln.de+49 221 478 85663
PRINCIPAL_INVESTIGATORAngela Kribs, Apl. Prof. Dr.

University Hospital Cologne

PRINCIPAL_INVESTIGATORMiguel A Alejandre Alcázar, Prof. Dr.

University Hospital Cologne

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026